Anuh Pharma Ltd has received approval from WHO Geneva prequalification for pyrimcthamine API which is used as anti-malarial drugs.
Anuh Pharma on Thursday said that the World Health Organisation (WHO) has suspended its products – Pyrazinamide and Sulfadoxine – from prequalified list of active pharmaceutical ingredients (API).
Anuh Pharma LTD fails EDQM Inspection
Anuh Pharma has rallied 9% to Rs 339 on the BSE in early morning trade after the pharmaceutical company said that it has received World Health Organization (WHO) prequalification for the product Sulfadoxine.
Global Active Pharmaceutical Ingredients Market 2015-2019